Nanotechnology Now

Our NanoNews Digest Sponsors





Heifer International

Wikipedia Affiliate Button


android tablet pc

Home > Press > Nanotechnology Company to Announce Breakthroughs

Abstract:
PharmaNova, a leader in nanotechnology-based Drug Delivery Systems, is due to exhibit at the 2009 annual meeting of the American Association of Pharmaceutical Scientists (AAPS) scheduled in Los Angeles, CA, from November 8 - 12.

Nanotechnology Company to Announce Breakthroughs

Victor, NY | Posted on September 30th, 2009

The Company will announce new technology breakthroughs in discussions with visitors to the exhibit. The meeting will be at Los Angeles Convention Center and the booth location is 2451.

NovaSperse(SM) technology is focused on the formation of stable amorphous nanoparticles with excellent reproducibility. This technology is being applied to both New Product Opportunities (NPOs) and Client Sponsored Projects (CSPs).

PharmaNova's proprietary NovaSperse(SM) technology offers proactive control of nanoparticle characteristics and is tailored to the unique chemistry of individual active pharmaceutical ingredients (APIs). PharmaNova's scientists are actively advancing the NovaSperse(SM) technology platform towards attaining a leadership position among nanotechnology-enabled drug delivery companies.

A nanometer is one-billionth of a meter; a human hair is roughly 100,000 nanometers wide; a human fingernail grows 1 nanometer every second; a sheet of paper is about 100,000 nanometers thick.

####

About PharmaNova Inc.
PharmaNova Inc. is a privately held, specialty pharmaceutical company founded on the re-positioning and enhancement of known drugs using its proprietary NovaSperse(SM) nanoparticle technology platform and other complementary drug delivery and formulation technologies. We address low-risk, fast-to-market products in areas of clear medical need and generate revenue from partnering and licensing strategies with commercialization partners worldwide. PharmaNova also provides contractual services for the NovaSperse(SM)-based formulation of client-owned APIs. PharmaNova's pipeline includes a (partnered) non-hormonal treatment for menopausal hot flashes and topical anti-infective and ophthalmic new product opportunities. PharmaNova and Altacor of Cambridge, England, have formed a strategic alliance to develop and commercialize a series of new prescription ophthalmic medical products based on PharmaNova's proprietary NovaSperse(SM) nanoparticle technology.

For more information, please click here

Contacts:
Tom Biviano
Director Business Development
585-413-4721 x102

Copyright © prnewswire

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Light pulses control graphene's electrical behavior: Finding could allow ultrafast switching of conduction, and possibly lead to new broadband light sensors August 1st, 2014

President Obama Meets U.S. Laureates of 2014 Kavli Prizes August 1st, 2014

Stanford researchers seek 'Holy Grail' in battery design: Pure lithium anode closer to reality with development of protective layer of interconnected carbon domes August 1st, 2014

Air Forceís 30-year plan seeks 'strategic agility' August 1st, 2014

Nanomedicine

Taking the guesswork out of cancer therapy: New molecular test kit predicts patientís survival and drug response August 1st, 2014

Arrowhead to Report Fiscal 2014 Third Quarter Financial Results- Conference Call Scheduled for Tuesday, August 12, 2014 - July 31st, 2014

New imaging agent provides better picture of the gut July 30th, 2014

Zenosense, Inc. July 29th, 2014

Announcements

Light pulses control graphene's electrical behavior: Finding could allow ultrafast switching of conduction, and possibly lead to new broadband light sensors August 1st, 2014

President Obama Meets U.S. Laureates of 2014 Kavli Prizes August 1st, 2014

Stanford researchers seek 'Holy Grail' in battery design: Pure lithium anode closer to reality with development of protective layer of interconnected carbon domes August 1st, 2014

Air Forceís 30-year plan seeks 'strategic agility' August 1st, 2014

Events/Classes

International Conference in Nanomaterials and Technologies CNT 2014 August 1st, 2014

Arrowhead to Report Fiscal 2014 Third Quarter Financial Results- Conference Call Scheduled for Tuesday, August 12, 2014 - July 31st, 2014

FLAG-ERA and TNT2014 join efforts: Graphene Networking at its higher level in Barcelona: Encourage the participation in a joint transnational call July 30th, 2014

FEI Unveils New Solutions for Faster Time-to-Analysis in Metals Research July 30th, 2014

Nanobiotechnology

Taking the guesswork out of cancer therapy: New molecular test kit predicts patientís survival and drug response August 1st, 2014

Harris & Harris Group Invests in Unique NYC Biotech Accelerator July 29th, 2014

Seeing is bead-lieving: Rice University scientists create model 'bead-spring' chains with tunable properties July 28th, 2014

FEI adds Phase Plate Technology and Titan Halo TEM to its Structural Biology Product Portfolio: New solutions provide the high-quality imaging and contrast necessary to analyze the 3D structure of molecules and molecular complexes July 28th, 2014

NanoNews-Digest
The latest news from around the world, FREE



  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More














ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project







© Copyright 1999-2014 7th Wave, Inc. All Rights Reserved PRIVACY POLICY :: CONTACT US :: STATS :: SITE MAP :: ADVERTISE